bioRASI’s clients benefit from its access to patients and special populations in the U.S., Europe and Asia, to achieve unparalleled scientific, clinical and business results significantly faster and at lower costs.
bioRASI accelerates the process of obtaining FDA approvals with a full spectrum of services, including:
bioRASI’s clients benefit from its access to patients and special populations in the U.S., Europe and Asia, to achieve unparalleled scientific, clinical and business results significantly faster and at lower costs.
bioRASI accelerates the process of obtaining FDA approvals with a full spectrum of services, including:
bioRASI Process Infrastructure (BPI-2012) is a comprehensive, well-structured set of documents that guides our project teams from the initial interactions with the Sponsor through regulatory agency submission. It integrates industry-leading project management practices with ICH-GCP compliant procedures to create a seamless process infrastructure that ensures optimal performance and the highest quality outcomes.
Like all top-tier performance management systems, BPI is continuously upgraded. We believe BPI contributes to bioRASI’s superiority in conducting clinical trials.